Vero biotech is an emerging biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions. At Vero Biotech, our mission is to improve the lives of patients by leading the development of innovative technologies for inhaled NO delivery in the acute care hospital setting and beyond, wherever Nitric Oxide treatment is needed. We strive to exceed customer expectations in terms of safety, efficacy, and growth by focusing on the science, development, and commercialization of our innovations.
View Top Employees from VERO BiotechWebsite | http://www.vero-biotech.com |
Revenue | $20 million |
Funding | $50 million |
Employees | 248 (248 on RocketReach) |
Address | 387 Technology Circle NW 125, Atlanta, Georgia 30303, US |
Phone | (678) 661-5701 |
Fax | (321) 206-8502 |
Technologies |
JavaScript,
HTML,
PHP
+66 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Medical Devices & Equipment, Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 80 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular VERO Biotech employee's phone or email?
The VERO Biotech annual revenue was $20 million in 2024.
Marc Morin is the CFO of VERO Biotech.
248 people are employed at VERO Biotech.
VERO Biotech is based in Atlanta, Georgia.
The NAICS codes for VERO Biotech are [3254, 325, 32].
The SIC codes for VERO Biotech are [283, 28, 80].